Tianjin Ringpu Bio-Technology Co.,Ltd.

¥17.27As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300119Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 0.32%
Div yield 2.32%
ROE 7.42%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.23
PE TTM 23.26
TSR TTM (18.01%)
Mkt cap ¥7.842B
ROIC 7.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
10.42%
(49.47%)
Buy 6|7|1|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.25
0.26
0.29
0.29
14.00%
12.42%
20.92%
18.40%
Revenue¥M
402.2
422.2
424.8
423.7
3.77%
6.48%
7.11%
7.11%
Peers (US$1.175B)
Cap (US$)
PE
1.208B
35.03x
1.122B
107.4x
1.179B
—
Capital
TTM
5Y
10Y
Leveragex
0.673
(0.315)
(0.232)
EBIT/Intx
2.409
0.242
0.233
Own earn%
165.61
25.81
11.65
Sh yield%
45.64
55.90
55.60
Owners
Insiders/Inst%
9.34
56.30
Short interest%
2.73
SBC / revenue%
3.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
21–26
$1 testx
0.0
Incr. ROIC%
5